Current Trials

F00422 CBD Sleep Study

Participate in a research study using a novel approach to insomnia relief with cannabinoid-based medications. Fusion is conducting this study as a fully virtual trial, meaning you can participate in this trial without having to visit our clinic!

If you have difficulties staying and falling asleep and have access to a phone & internet, you may be eligible to participate.

Head to for more information or to sign up for this virtual trial.


Eligibility requirements

  • Age: 18-65
  • Sex:
  • Medication: Exclusionary Medications – Sedatives (benzodiazepines, z drugs, agomelatine, suvorexant, sodium oxybate, sedating antidepresants, sedating antihistamines, antipsychotics, melatonin, valerian) within 1 week of Day 1; Opioids (morphine, codeine, oxycodone, methadone, buprenorphine, fentanyl, tramadol, tapentadol, hydromorphone) within 1 week of Day 1; Stimulants (methylphenidate, dexamphetamine, modafinil, phentermine, pseudoephedrine) within 1 week of Day 1; Cannabinoids or cannabinoid-based medicine within 3 months of Day 1.
  • Medical History: Inclusion Criteria – Insomnia symptoms over the past month at pre-screening Exclusion Criteria – Excessive caffeine use (>600mg caffeine of apporx 6 cups of caffeinated beverage a day); Excessive alcohol use (no more than 10 standard drinks per week and no more than 4 standard drinks per day); Cannabis dependence or drug/alcohol dependence within past 2 years; Use of anticoagulant drugs or those known to be metabolised by CYP450 enzymes.

Outpatient Visits

  • No in-person visits


  • $400 if you complete the trial

How to apply

To register your interest in this trial, please complete this form, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.